A Glance into MTHFR Deficiency at a Molecular Level.

MTHFR deficiency MTHFR variants consensus method disease HMM models disease related variations functional annotation protein-protein interactions solvent accessibility structural annotation ΔΔG predictions

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Dec 2021
Historique:
received: 11 10 2021
revised: 03 12 2021
accepted: 21 12 2021
entrez: 11 1 2022
pubmed: 12 1 2022
medline: 2 2 2022
Statut: epublish

Résumé

MTHFR deficiency still deserves an investigation to associate the phenotype to protein structure variations. To this aim, considering the MTHFR wild type protein structure, with a catalytic and a regulatory domain and taking advantage of state-of-the-art computational tools, we explore the properties of 72 missense variations known to be disease associated. By computing the thermodynamic ΔΔG change according to a consensus method that we recently introduced, we find that 61% of the disease-related variations destabilize the protein, are present both in the catalytic and regulatory domain and correspond to known biochemical deficiencies. The propensity of solvent accessible residues to be involved in protein-protein interaction sites indicates that most of the interacting residues are located in the regulatory domain, and that only three of them, located at the interface of the functional protein homodimer, are both disease-related and destabilizing. Finally, we compute the protein architecture with Hidden Markov Models, one from Pfam for the catalytic domain and the second computed in house for the regulatory domain. We show that patterns of disease-associated, physicochemical variation types, both in the catalytic and regulatory domains, are unique for the MTHFR deficiency when mapped into the protein architecture.

Identifiants

pubmed: 35008593
pii: ijms23010167
doi: 10.3390/ijms23010167
pmc: PMC8745156
pii:
doi:

Substances chimiques

MTHFR protein, human EC 1.5.1.20
Methylenetetrahydrofolate Reductase (NADPH2) EC 1.5.1.20

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : PRIN project 2017483NH8

Références

Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12810-5
pubmed: 10536004
Hum Mutat. 2015 Jun;36(6):611-21
pubmed: 25736335
Hum Mutat. 2016 May;37(5):427-38
pubmed: 26872964
Bioinformatics. 2016 Aug 15;32(16):2542-4
pubmed: 27153629
Biochimie. 2021 Apr;183:100-107
pubmed: 33476699
J Biol Chem. 2020 Nov 20;295(47):16037-16057
pubmed: 32934008
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14853-8
pubmed: 11742092
Nat Genet. 1995 May;10(1):111-3
pubmed: 7647779
Hum Mutat. 2011 Oct;32(10):1161-70
pubmed: 21853506
Bioinformatics. 2018 Nov 1;34(21):3659-3665
pubmed: 29718106
Front Mol Biosci. 2021 Jan 07;7:626363
pubmed: 33490109
Int J Mol Sci. 2019 Mar 27;20(7):
pubmed: 30934684
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W382-8
pubmed: 15980494
Cell Metab. 2017 Jan 10;25(1):27-42
pubmed: 27641100
Front Mol Biosci. 2021 May 07;8:617016
pubmed: 34026820
J Inherit Metab Dis. 2019 Jul;42(4):673-685
pubmed: 30693532
Nat Commun. 2018 Jun 11;9(1):2261
pubmed: 29891918
Bioinformatics. 2017 Jun 1;33(11):1656-1663
pubmed: 28130235

Auteurs

Castrense Savojardo (C)

Biocomputing Group, Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.

Giulia Babbi (G)

Biocomputing Group, Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.

Davide Baldazzi (D)

Biocomputing Group, Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.

Pier Luigi Martelli (PL)

Biocomputing Group, Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.

Rita Casadio (R)

Biocomputing Group, Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.
Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), Italian National Research Council (CNR), 70126 Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH